Revisão Revisado por pares

Screening for ovarian cancer

2003; Wiley; Volume: 178; Issue: 12 Linguagem: Inglês

10.5694/j.1326-5377.2003.tb05399.x

ISSN

1326-5377

Autores

Cleola Anderiesz, Michael Quinn,

Tópico(s)

Endometrial and Cervical Cancer Treatments

Resumo

Ovarian cancer is the leading cause of death from gynaecological malignancies. No precancerous lesions have been identified. Bimanual examination has not been proven to be of value as a screening test. Transvaginal ultrasound examination, with or without measurement of CA 125 levels, is currently being evaluated for population screening. Women at high risk of ovarian cancer should be screened annually — with measurement of CA 125 level and transvaginal ultrasound examination.

Referência(s)